Adapt or perish? Assessing the recent shift in the European research funding arena from ‘ELSA’ to ‘RRI’
Abstract Two decades ago, in 1994, in the context of the $ 4^{th} $ EU Framework Programme, ELSA was introduced as a label for developing and funding research into the ethical, legal and social aspects of emerging sciences and technologies. Currently, particularly in the context of EU funding initia...
Ausführliche Beschreibung
Autor*in: |
Zwart, Hub [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2014 |
---|
Schlagwörter: |
---|
Anmerkung: |
© Zwart et al.; licensee Springer 2014. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( |
---|
Übergeordnetes Werk: |
Enthalten in: Genomics, society and policy - Lancaster : CESAGen, 2005, 10(2014), 1 vom: 14. Mai |
---|---|
Übergeordnetes Werk: |
volume:10 ; year:2014 ; number:1 ; day:14 ; month:05 |
Links: |
---|
DOI / URN: |
10.1186/s40504-014-0011-x |
---|
Katalog-ID: |
SPR036550582 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | SPR036550582 | ||
003 | DE-627 | ||
005 | 20230519142618.0 | ||
007 | cr uuu---uuuuu | ||
008 | 201007s2014 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1186/s40504-014-0011-x |2 doi | |
035 | |a (DE-627)SPR036550582 | ||
035 | |a (SPR)s40504-014-0011-x-e | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Zwart, Hub |e verfasserin |4 aut | |
245 | 1 | 0 | |a Adapt or perish? Assessing the recent shift in the European research funding arena from ‘ELSA’ to ‘RRI’ |
264 | 1 | |c 2014 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a © Zwart et al.; licensee Springer 2014. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( | ||
520 | |a Abstract Two decades ago, in 1994, in the context of the $ 4^{th} $ EU Framework Programme, ELSA was introduced as a label for developing and funding research into the ethical, legal and social aspects of emerging sciences and technologies. Currently, particularly in the context of EU funding initiatives such as Horizon2020, a new label has been forged, namely Responsible Research and Innovation (RRI). What is implied in this metonymy, this semantic shift? What is so new about RRI in comparison to ELSA? First of all, for both labels, the signifier (S) was introduced in a top-down manner, well before the concept that was signified by it (s) had acquired a clear and stable profile. In other words, the signifier preceded (and helped or helps to shape) the research strategies actually covered by these labels (the precedence of the signifier over the signified: S/s). Moreover, the newness of RRI does not reside in its interactive and anticipatory orientation, as is suggested by authors who introduced the term, but rather in its emphases on social-economic impacts (valorisation, employment and competitiveness). | ||
650 | 4 | |a Responsible Research |7 (dpeaa)DE-He213 | |
650 | 4 | |a Responsible Innovation |7 (dpeaa)DE-He213 | |
650 | 4 | |a ESRC Genomic Network |7 (dpeaa)DE-He213 | |
650 | 4 | |a Innovation Trajectory |7 (dpeaa)DE-He213 | |
650 | 4 | |a Netherlands Genomic Initiative |7 (dpeaa)DE-He213 | |
700 | 1 | |a Landeweerd, Laurens |4 aut | |
700 | 1 | |a van Rooij, Arjan |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Genomics, society and policy |d Lancaster : CESAGen, 2005 |g 10(2014), 1 vom: 14. Mai |w (DE-627)495740667 |w (DE-600)2197912-1 |x 1746-5354 |7 nnns |
773 | 1 | 8 | |g volume:10 |g year:2014 |g number:1 |g day:14 |g month:05 |
856 | 4 | 0 | |u https://dx.doi.org/10.1186/s40504-014-0011-x |z kostenfrei |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_SPRINGER | ||
912 | |a SSG-OLC-PHA | ||
951 | |a AR | ||
952 | |d 10 |j 2014 |e 1 |b 14 |c 05 |
author_variant |
h z hz l l ll r a v ra rav |
---|---|
matchkey_str |
article:17465354:2014----::dpoprsassighrcnsitnherparsacfn |
hierarchy_sort_str |
2014 |
publishDate |
2014 |
allfields |
10.1186/s40504-014-0011-x doi (DE-627)SPR036550582 (SPR)s40504-014-0011-x-e DE-627 ger DE-627 rakwb eng Zwart, Hub verfasserin aut Adapt or perish? Assessing the recent shift in the European research funding arena from ‘ELSA’ to ‘RRI’ 2014 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Zwart et al.; licensee Springer 2014. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( Abstract Two decades ago, in 1994, in the context of the $ 4^{th} $ EU Framework Programme, ELSA was introduced as a label for developing and funding research into the ethical, legal and social aspects of emerging sciences and technologies. Currently, particularly in the context of EU funding initiatives such as Horizon2020, a new label has been forged, namely Responsible Research and Innovation (RRI). What is implied in this metonymy, this semantic shift? What is so new about RRI in comparison to ELSA? First of all, for both labels, the signifier (S) was introduced in a top-down manner, well before the concept that was signified by it (s) had acquired a clear and stable profile. In other words, the signifier preceded (and helped or helps to shape) the research strategies actually covered by these labels (the precedence of the signifier over the signified: S/s). Moreover, the newness of RRI does not reside in its interactive and anticipatory orientation, as is suggested by authors who introduced the term, but rather in its emphases on social-economic impacts (valorisation, employment and competitiveness). Responsible Research (dpeaa)DE-He213 Responsible Innovation (dpeaa)DE-He213 ESRC Genomic Network (dpeaa)DE-He213 Innovation Trajectory (dpeaa)DE-He213 Netherlands Genomic Initiative (dpeaa)DE-He213 Landeweerd, Laurens aut van Rooij, Arjan aut Enthalten in Genomics, society and policy Lancaster : CESAGen, 2005 10(2014), 1 vom: 14. Mai (DE-627)495740667 (DE-600)2197912-1 1746-5354 nnns volume:10 year:2014 number:1 day:14 month:05 https://dx.doi.org/10.1186/s40504-014-0011-x kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA AR 10 2014 1 14 05 |
spelling |
10.1186/s40504-014-0011-x doi (DE-627)SPR036550582 (SPR)s40504-014-0011-x-e DE-627 ger DE-627 rakwb eng Zwart, Hub verfasserin aut Adapt or perish? Assessing the recent shift in the European research funding arena from ‘ELSA’ to ‘RRI’ 2014 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Zwart et al.; licensee Springer 2014. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( Abstract Two decades ago, in 1994, in the context of the $ 4^{th} $ EU Framework Programme, ELSA was introduced as a label for developing and funding research into the ethical, legal and social aspects of emerging sciences and technologies. Currently, particularly in the context of EU funding initiatives such as Horizon2020, a new label has been forged, namely Responsible Research and Innovation (RRI). What is implied in this metonymy, this semantic shift? What is so new about RRI in comparison to ELSA? First of all, for both labels, the signifier (S) was introduced in a top-down manner, well before the concept that was signified by it (s) had acquired a clear and stable profile. In other words, the signifier preceded (and helped or helps to shape) the research strategies actually covered by these labels (the precedence of the signifier over the signified: S/s). Moreover, the newness of RRI does not reside in its interactive and anticipatory orientation, as is suggested by authors who introduced the term, but rather in its emphases on social-economic impacts (valorisation, employment and competitiveness). Responsible Research (dpeaa)DE-He213 Responsible Innovation (dpeaa)DE-He213 ESRC Genomic Network (dpeaa)DE-He213 Innovation Trajectory (dpeaa)DE-He213 Netherlands Genomic Initiative (dpeaa)DE-He213 Landeweerd, Laurens aut van Rooij, Arjan aut Enthalten in Genomics, society and policy Lancaster : CESAGen, 2005 10(2014), 1 vom: 14. Mai (DE-627)495740667 (DE-600)2197912-1 1746-5354 nnns volume:10 year:2014 number:1 day:14 month:05 https://dx.doi.org/10.1186/s40504-014-0011-x kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA AR 10 2014 1 14 05 |
allfields_unstemmed |
10.1186/s40504-014-0011-x doi (DE-627)SPR036550582 (SPR)s40504-014-0011-x-e DE-627 ger DE-627 rakwb eng Zwart, Hub verfasserin aut Adapt or perish? Assessing the recent shift in the European research funding arena from ‘ELSA’ to ‘RRI’ 2014 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Zwart et al.; licensee Springer 2014. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( Abstract Two decades ago, in 1994, in the context of the $ 4^{th} $ EU Framework Programme, ELSA was introduced as a label for developing and funding research into the ethical, legal and social aspects of emerging sciences and technologies. Currently, particularly in the context of EU funding initiatives such as Horizon2020, a new label has been forged, namely Responsible Research and Innovation (RRI). What is implied in this metonymy, this semantic shift? What is so new about RRI in comparison to ELSA? First of all, for both labels, the signifier (S) was introduced in a top-down manner, well before the concept that was signified by it (s) had acquired a clear and stable profile. In other words, the signifier preceded (and helped or helps to shape) the research strategies actually covered by these labels (the precedence of the signifier over the signified: S/s). Moreover, the newness of RRI does not reside in its interactive and anticipatory orientation, as is suggested by authors who introduced the term, but rather in its emphases on social-economic impacts (valorisation, employment and competitiveness). Responsible Research (dpeaa)DE-He213 Responsible Innovation (dpeaa)DE-He213 ESRC Genomic Network (dpeaa)DE-He213 Innovation Trajectory (dpeaa)DE-He213 Netherlands Genomic Initiative (dpeaa)DE-He213 Landeweerd, Laurens aut van Rooij, Arjan aut Enthalten in Genomics, society and policy Lancaster : CESAGen, 2005 10(2014), 1 vom: 14. Mai (DE-627)495740667 (DE-600)2197912-1 1746-5354 nnns volume:10 year:2014 number:1 day:14 month:05 https://dx.doi.org/10.1186/s40504-014-0011-x kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA AR 10 2014 1 14 05 |
allfieldsGer |
10.1186/s40504-014-0011-x doi (DE-627)SPR036550582 (SPR)s40504-014-0011-x-e DE-627 ger DE-627 rakwb eng Zwart, Hub verfasserin aut Adapt or perish? Assessing the recent shift in the European research funding arena from ‘ELSA’ to ‘RRI’ 2014 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Zwart et al.; licensee Springer 2014. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( Abstract Two decades ago, in 1994, in the context of the $ 4^{th} $ EU Framework Programme, ELSA was introduced as a label for developing and funding research into the ethical, legal and social aspects of emerging sciences and technologies. Currently, particularly in the context of EU funding initiatives such as Horizon2020, a new label has been forged, namely Responsible Research and Innovation (RRI). What is implied in this metonymy, this semantic shift? What is so new about RRI in comparison to ELSA? First of all, for both labels, the signifier (S) was introduced in a top-down manner, well before the concept that was signified by it (s) had acquired a clear and stable profile. In other words, the signifier preceded (and helped or helps to shape) the research strategies actually covered by these labels (the precedence of the signifier over the signified: S/s). Moreover, the newness of RRI does not reside in its interactive and anticipatory orientation, as is suggested by authors who introduced the term, but rather in its emphases on social-economic impacts (valorisation, employment and competitiveness). Responsible Research (dpeaa)DE-He213 Responsible Innovation (dpeaa)DE-He213 ESRC Genomic Network (dpeaa)DE-He213 Innovation Trajectory (dpeaa)DE-He213 Netherlands Genomic Initiative (dpeaa)DE-He213 Landeweerd, Laurens aut van Rooij, Arjan aut Enthalten in Genomics, society and policy Lancaster : CESAGen, 2005 10(2014), 1 vom: 14. Mai (DE-627)495740667 (DE-600)2197912-1 1746-5354 nnns volume:10 year:2014 number:1 day:14 month:05 https://dx.doi.org/10.1186/s40504-014-0011-x kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA AR 10 2014 1 14 05 |
allfieldsSound |
10.1186/s40504-014-0011-x doi (DE-627)SPR036550582 (SPR)s40504-014-0011-x-e DE-627 ger DE-627 rakwb eng Zwart, Hub verfasserin aut Adapt or perish? Assessing the recent shift in the European research funding arena from ‘ELSA’ to ‘RRI’ 2014 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Zwart et al.; licensee Springer 2014. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( Abstract Two decades ago, in 1994, in the context of the $ 4^{th} $ EU Framework Programme, ELSA was introduced as a label for developing and funding research into the ethical, legal and social aspects of emerging sciences and technologies. Currently, particularly in the context of EU funding initiatives such as Horizon2020, a new label has been forged, namely Responsible Research and Innovation (RRI). What is implied in this metonymy, this semantic shift? What is so new about RRI in comparison to ELSA? First of all, for both labels, the signifier (S) was introduced in a top-down manner, well before the concept that was signified by it (s) had acquired a clear and stable profile. In other words, the signifier preceded (and helped or helps to shape) the research strategies actually covered by these labels (the precedence of the signifier over the signified: S/s). Moreover, the newness of RRI does not reside in its interactive and anticipatory orientation, as is suggested by authors who introduced the term, but rather in its emphases on social-economic impacts (valorisation, employment and competitiveness). Responsible Research (dpeaa)DE-He213 Responsible Innovation (dpeaa)DE-He213 ESRC Genomic Network (dpeaa)DE-He213 Innovation Trajectory (dpeaa)DE-He213 Netherlands Genomic Initiative (dpeaa)DE-He213 Landeweerd, Laurens aut van Rooij, Arjan aut Enthalten in Genomics, society and policy Lancaster : CESAGen, 2005 10(2014), 1 vom: 14. Mai (DE-627)495740667 (DE-600)2197912-1 1746-5354 nnns volume:10 year:2014 number:1 day:14 month:05 https://dx.doi.org/10.1186/s40504-014-0011-x kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA AR 10 2014 1 14 05 |
language |
English |
source |
Enthalten in Genomics, society and policy 10(2014), 1 vom: 14. Mai volume:10 year:2014 number:1 day:14 month:05 |
sourceStr |
Enthalten in Genomics, society and policy 10(2014), 1 vom: 14. Mai volume:10 year:2014 number:1 day:14 month:05 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
topic_facet |
Responsible Research Responsible Innovation ESRC Genomic Network Innovation Trajectory Netherlands Genomic Initiative |
isfreeaccess_bool |
true |
container_title |
Genomics, society and policy |
authorswithroles_txt_mv |
Zwart, Hub @@aut@@ Landeweerd, Laurens @@aut@@ van Rooij, Arjan @@aut@@ |
publishDateDaySort_date |
2014-05-14T00:00:00Z |
hierarchy_top_id |
495740667 |
id |
SPR036550582 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR036550582</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519142618.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2014 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1186/s40504-014-0011-x</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR036550582</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)s40504-014-0011-x-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Zwart, Hub</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Adapt or perish? Assessing the recent shift in the European research funding arena from ‘ELSA’ to ‘RRI’</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Zwart et al.; licensee Springer 2014. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Abstract Two decades ago, in 1994, in the context of the $ 4^{th} $ EU Framework Programme, ELSA was introduced as a label for developing and funding research into the ethical, legal and social aspects of emerging sciences and technologies. Currently, particularly in the context of EU funding initiatives such as Horizon2020, a new label has been forged, namely Responsible Research and Innovation (RRI). What is implied in this metonymy, this semantic shift? What is so new about RRI in comparison to ELSA? First of all, for both labels, the signifier (S) was introduced in a top-down manner, well before the concept that was signified by it (s) had acquired a clear and stable profile. In other words, the signifier preceded (and helped or helps to shape) the research strategies actually covered by these labels (the precedence of the signifier over the signified: S/s). Moreover, the newness of RRI does not reside in its interactive and anticipatory orientation, as is suggested by authors who introduced the term, but rather in its emphases on social-economic impacts (valorisation, employment and competitiveness).</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Responsible Research</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Responsible Innovation</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">ESRC Genomic Network</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Innovation Trajectory</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Netherlands Genomic Initiative</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Landeweerd, Laurens</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">van Rooij, Arjan</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Genomics, society and policy</subfield><subfield code="d">Lancaster : CESAGen, 2005</subfield><subfield code="g">10(2014), 1 vom: 14. Mai</subfield><subfield code="w">(DE-627)495740667</subfield><subfield code="w">(DE-600)2197912-1</subfield><subfield code="x">1746-5354</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:10</subfield><subfield code="g">year:2014</subfield><subfield code="g">number:1</subfield><subfield code="g">day:14</subfield><subfield code="g">month:05</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1186/s40504-014-0011-x</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">10</subfield><subfield code="j">2014</subfield><subfield code="e">1</subfield><subfield code="b">14</subfield><subfield code="c">05</subfield></datafield></record></collection>
|
author |
Zwart, Hub |
spellingShingle |
Zwart, Hub misc Responsible Research misc Responsible Innovation misc ESRC Genomic Network misc Innovation Trajectory misc Netherlands Genomic Initiative Adapt or perish? Assessing the recent shift in the European research funding arena from ‘ELSA’ to ‘RRI’ |
authorStr |
Zwart, Hub |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)495740667 |
format |
electronic Article |
delete_txt_mv |
keep |
author_role |
aut aut aut |
collection |
springer |
remote_str |
true |
illustrated |
Not Illustrated |
issn |
1746-5354 |
topic_title |
Adapt or perish? Assessing the recent shift in the European research funding arena from ‘ELSA’ to ‘RRI’ Responsible Research (dpeaa)DE-He213 Responsible Innovation (dpeaa)DE-He213 ESRC Genomic Network (dpeaa)DE-He213 Innovation Trajectory (dpeaa)DE-He213 Netherlands Genomic Initiative (dpeaa)DE-He213 |
topic |
misc Responsible Research misc Responsible Innovation misc ESRC Genomic Network misc Innovation Trajectory misc Netherlands Genomic Initiative |
topic_unstemmed |
misc Responsible Research misc Responsible Innovation misc ESRC Genomic Network misc Innovation Trajectory misc Netherlands Genomic Initiative |
topic_browse |
misc Responsible Research misc Responsible Innovation misc ESRC Genomic Network misc Innovation Trajectory misc Netherlands Genomic Initiative |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
cr |
hierarchy_parent_title |
Genomics, society and policy |
hierarchy_parent_id |
495740667 |
hierarchy_top_title |
Genomics, society and policy |
isfreeaccess_txt |
true |
familylinks_str_mv |
(DE-627)495740667 (DE-600)2197912-1 |
title |
Adapt or perish? Assessing the recent shift in the European research funding arena from ‘ELSA’ to ‘RRI’ |
ctrlnum |
(DE-627)SPR036550582 (SPR)s40504-014-0011-x-e |
title_full |
Adapt or perish? Assessing the recent shift in the European research funding arena from ‘ELSA’ to ‘RRI’ |
author_sort |
Zwart, Hub |
journal |
Genomics, society and policy |
journalStr |
Genomics, society and policy |
lang_code |
eng |
isOA_bool |
true |
recordtype |
marc |
publishDateSort |
2014 |
contenttype_str_mv |
txt |
author_browse |
Zwart, Hub Landeweerd, Laurens van Rooij, Arjan |
container_volume |
10 |
format_se |
Elektronische Aufsätze |
author-letter |
Zwart, Hub |
doi_str_mv |
10.1186/s40504-014-0011-x |
title_sort |
adapt or perish? assessing the recent shift in the european research funding arena from ‘elsa’ to ‘rri’ |
title_auth |
Adapt or perish? Assessing the recent shift in the European research funding arena from ‘ELSA’ to ‘RRI’ |
abstract |
Abstract Two decades ago, in 1994, in the context of the $ 4^{th} $ EU Framework Programme, ELSA was introduced as a label for developing and funding research into the ethical, legal and social aspects of emerging sciences and technologies. Currently, particularly in the context of EU funding initiatives such as Horizon2020, a new label has been forged, namely Responsible Research and Innovation (RRI). What is implied in this metonymy, this semantic shift? What is so new about RRI in comparison to ELSA? First of all, for both labels, the signifier (S) was introduced in a top-down manner, well before the concept that was signified by it (s) had acquired a clear and stable profile. In other words, the signifier preceded (and helped or helps to shape) the research strategies actually covered by these labels (the precedence of the signifier over the signified: S/s). Moreover, the newness of RRI does not reside in its interactive and anticipatory orientation, as is suggested by authors who introduced the term, but rather in its emphases on social-economic impacts (valorisation, employment and competitiveness). © Zwart et al.; licensee Springer 2014. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( |
abstractGer |
Abstract Two decades ago, in 1994, in the context of the $ 4^{th} $ EU Framework Programme, ELSA was introduced as a label for developing and funding research into the ethical, legal and social aspects of emerging sciences and technologies. Currently, particularly in the context of EU funding initiatives such as Horizon2020, a new label has been forged, namely Responsible Research and Innovation (RRI). What is implied in this metonymy, this semantic shift? What is so new about RRI in comparison to ELSA? First of all, for both labels, the signifier (S) was introduced in a top-down manner, well before the concept that was signified by it (s) had acquired a clear and stable profile. In other words, the signifier preceded (and helped or helps to shape) the research strategies actually covered by these labels (the precedence of the signifier over the signified: S/s). Moreover, the newness of RRI does not reside in its interactive and anticipatory orientation, as is suggested by authors who introduced the term, but rather in its emphases on social-economic impacts (valorisation, employment and competitiveness). © Zwart et al.; licensee Springer 2014. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( |
abstract_unstemmed |
Abstract Two decades ago, in 1994, in the context of the $ 4^{th} $ EU Framework Programme, ELSA was introduced as a label for developing and funding research into the ethical, legal and social aspects of emerging sciences and technologies. Currently, particularly in the context of EU funding initiatives such as Horizon2020, a new label has been forged, namely Responsible Research and Innovation (RRI). What is implied in this metonymy, this semantic shift? What is so new about RRI in comparison to ELSA? First of all, for both labels, the signifier (S) was introduced in a top-down manner, well before the concept that was signified by it (s) had acquired a clear and stable profile. In other words, the signifier preceded (and helped or helps to shape) the research strategies actually covered by these labels (the precedence of the signifier over the signified: S/s). Moreover, the newness of RRI does not reside in its interactive and anticipatory orientation, as is suggested by authors who introduced the term, but rather in its emphases on social-economic impacts (valorisation, employment and competitiveness). © Zwart et al.; licensee Springer 2014. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( |
collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA |
container_issue |
1 |
title_short |
Adapt or perish? Assessing the recent shift in the European research funding arena from ‘ELSA’ to ‘RRI’ |
url |
https://dx.doi.org/10.1186/s40504-014-0011-x |
remote_bool |
true |
author2 |
Landeweerd, Laurens van Rooij, Arjan |
author2Str |
Landeweerd, Laurens van Rooij, Arjan |
ppnlink |
495740667 |
mediatype_str_mv |
c |
isOA_txt |
true |
hochschulschrift_bool |
false |
doi_str |
10.1186/s40504-014-0011-x |
up_date |
2024-07-03T18:18:30.863Z |
_version_ |
1803582922675978240 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR036550582</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519142618.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2014 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1186/s40504-014-0011-x</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR036550582</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)s40504-014-0011-x-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Zwart, Hub</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Adapt or perish? Assessing the recent shift in the European research funding arena from ‘ELSA’ to ‘RRI’</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Zwart et al.; licensee Springer 2014. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Abstract Two decades ago, in 1994, in the context of the $ 4^{th} $ EU Framework Programme, ELSA was introduced as a label for developing and funding research into the ethical, legal and social aspects of emerging sciences and technologies. Currently, particularly in the context of EU funding initiatives such as Horizon2020, a new label has been forged, namely Responsible Research and Innovation (RRI). What is implied in this metonymy, this semantic shift? What is so new about RRI in comparison to ELSA? First of all, for both labels, the signifier (S) was introduced in a top-down manner, well before the concept that was signified by it (s) had acquired a clear and stable profile. In other words, the signifier preceded (and helped or helps to shape) the research strategies actually covered by these labels (the precedence of the signifier over the signified: S/s). Moreover, the newness of RRI does not reside in its interactive and anticipatory orientation, as is suggested by authors who introduced the term, but rather in its emphases on social-economic impacts (valorisation, employment and competitiveness).</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Responsible Research</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Responsible Innovation</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">ESRC Genomic Network</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Innovation Trajectory</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Netherlands Genomic Initiative</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Landeweerd, Laurens</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">van Rooij, Arjan</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Genomics, society and policy</subfield><subfield code="d">Lancaster : CESAGen, 2005</subfield><subfield code="g">10(2014), 1 vom: 14. Mai</subfield><subfield code="w">(DE-627)495740667</subfield><subfield code="w">(DE-600)2197912-1</subfield><subfield code="x">1746-5354</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:10</subfield><subfield code="g">year:2014</subfield><subfield code="g">number:1</subfield><subfield code="g">day:14</subfield><subfield code="g">month:05</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1186/s40504-014-0011-x</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">10</subfield><subfield code="j">2014</subfield><subfield code="e">1</subfield><subfield code="b">14</subfield><subfield code="c">05</subfield></datafield></record></collection>
|
score |
7.400943 |